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0.43±0.13 cm and 0.47±0.16 cm were observed for the GTV and 
parotids respectively. 
The comparison between planned, delivered and adaptive dose has 
been summarized in Table 1.  
 
  
Conclusions: The results obtained using SA software are encouraging. 
The accuracy of SA, for different quality images (KVCT and MVCT), is 
good, allowing a saving in process time. Furthermore, the SA tool, 
combined with an in house software, could enable the estimation of 
the cumulative dose actually delivered to the patients due to 
anatomical changes. However, the not optimal quality of MVCT images 
could limit our observations, therefore further analysis are needed to 
confirm these preliminary results.  
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Purpose/Objective: In order to understand which dosimetric 
parameters could be chosen as predictive indexes for genitourinary 
complications of prostate treatment, this study asses the inter-
fraction bladder motion and investigates its impact on the Dose–
Volume and Dose-Surface Histograms (DVH - DSH). 
Materials and Methods: Eight prostate cancer patients treated with 
radical intent were unrolled. For each patients a Tomotherapy plan 
was generated prescribing 70 Gy (2.5 Gy/fr X 28fr) to the 95% of the 
PTV volume. To avoid a setup errors, for each fraction a pretreatment 
MVCT image was acquired and a rigid registration on anatomical 
matches between MVCT and planning CT was performed and validate 
by the physicians. On each registered MVCT, bladder was contoured 
(using ECLIPSE TPS, Varian Medical System, Palo Alto, CA) by a single 
observer and copied on the planning CT, in order to have for the same 
planning dose distribution 28 per-treatment plus one planning bladder 
contours for each patients. Bladder DVH and dose surface histogram 
(DSH) were then computed using a dedicated software (VODCA, 
MSS,Inc.). Per-treatment DVHs and DSHs (DVHt and DSHt) were 
compared with planned DVHs and DSHs respectively (DVHp and DSHp). 
The difference mean and the SD between these parameters, were 
calculated and considered for the analysis in term of percentage (%) 
and absolute volume/surface. The trend of the dose-surface factors, 
by the evaluation of relative surface that receive at least 72 Gy (S72), 
was studied. 
Results: Random variations of volume and DVHs due to variable filling 
content of the bladder were found; a trend to be more empty during 
therapy with respect to planning CT was also found: the mean value of 
the volume for the 28th fractions and planning CT are respectively 171 
cm3 and 233 cm3 (p<0.05), while the mean surface value are 204 cm2 
vs. 231cm2 (p=0.056). For the eight patients unrolled a more robust 
trend was observed for the DSH respect to DVH when are take in 
account the differences between the planning and per-treatment 
parameters as well those showed in Figure 1, where the standard 
deviations are represented as dashed lines. In three patients, an 
important reduction of the surface, in % values, receiving high doses 
was observed during the treatment (Figure 2). T-Student test showed 
an overall statistically significant reduction of S72 (DSHt– DSHp) with a 
mean difference equal to -1.5% of the total bladder surface (p=0.052). 
 
  
Conclusions: Despite the random variation of the bladder volume 
shape and position during the treatment, our preliminary results show 
that the DSH could be more robust than the DVH to be a predictive 
index for the bladder toxicity. The reduction of the surface value 
which receive high doses in three patients was probably related to the 
prostate edema induced by the treatment that causes a vertical shift 
of the bladder outside the high dose region. 
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Purpose/Objective: To take into account setup uncertainties and 
patient breathing, the intensity extension of IMRT treatment fields in 
the superficial parts of the body could be generated. This study 
investigates (i) the dosimetric impact of uncorrected setup errors on 
superficial breast doses in cases of the IMRT plans with and without 
intensity extension (IE), (ii) the sufficiency of the applicable fluence 
extension margin. 
Materials and Methods: 5-field IMRT plans with and without IE outside 
the breast contour were created for 10 consecutive patients. The 
fluence was extended outside the body up to 8mm in the anterolateral 
(AL) direction using the skin flash (SF) tool method applied in an 
Eclipse TPS. To evaluate sufficiency of the SF margin, the following 
structure in the superficial region (SR) 0-8 mm beneath the skin 
surface was created for the plans with IE and without IE. The 
displacement results of setup errors were obtained by 2D kV images 
and after applying the corrections the portal images were acquired for 
the two most external beams used to verify the sufficiency of the SF 
margin. According to the acquired setup errors, the isocenter was 
shifted in the treatment planning system to simulate uncorrected dose 
distributions. The evaluation of the displacement impact was 
performed based on DVH analyses of the SR, PTV doses and the 
internal target coverage (ITC) for PTV defined as (D5% – D95%)/D95% for 
plans with IE against plans without IE. 
Results: Using the SF method increased the average number of MU by 
15%, up to 158 MU. The AL vector displacement >5mm of up to 17mm 
occurred on 44/93 (47%) occasions. Table 1 presents the differences 
between the dosimetric values obtained for the SR, PTV and  ITC for 
the IMRT plans with and without IE as a consequence of the 
uncorrected setup errors. The AL vector displacement was divided 
into three subgroups depending on the influence of setup error on the 
analyzed values. Group systematic (and random) setup errors 
detected by portal images were 2.2 (3.2) mm laterally, 1.6 (4.0) mm 
vertically and the maximum displacement in the AL direction did not 
exceed 8mm. 
Table 1 presents the mean differences and standard deviations in 
percentage between the dosimetric values obtained for the breast 
IMRT plans with and without IE as a consequence of the uncorrected 
setup errors; Dmean=mean dose, Dmax=maximum dose. 
